2.67USD
597.60 MUSD
3.70 BUSD
221.84 M
About Incyte Corporation
Sector
CEO
Herve Hoppenot
Headquarters
Wilmington
Website
Employees (FY)
2.52 K
Founded
1991
ISIN
US45337C1027
FIGI
BBG000BNPSQ9
Incyte Corp. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of proprietary therapeutics. It focuses on hematology and oncology, and inflammation and autoimmunity therapeutic areas. The company was founded in April 1991 and is headquartered in Wilmington, DE.
INCY setting up for a Base BreakoutINCY has been basing for a few months under this $66 level
Keep an eye out for the exit of the stage 1 base into a stage 2 breakout through $66 to the upside
INCY - Incyte Bullish BreakoutOn this 5 Month Daily Chart of Incyte you can clearly see the Bearish Trend that included the last 6 weeks of each daily candle trending below the 7 Day EMA until just the last 2 trading days where the bottom was made and INCY finally broke above the 7 day EMA on very good strenth with much higher v
INCY Buy Opportunity "Pause Rebounders "Pause Rebounder Stock
Market Watch:
Because until equity markets begin to notice. it’s unlikely politicians will feel compelled to act. Political brinkmanship will fuel market volatility — the VIX (VIX) trades to 40 in 2023; SPX retests the 3,800 floor. The similarities to 2011 (where arguably Dem
$INCY with a Bullish outlook following its earnings #Stocks The PEAD projected a Bullish outlook for $INCY after a Positive Under reaction following its earnings release placing the stock in drift A with an expected accuracy of 85.71%.
$INCY with a Bearish outlook following its earnings #Stocks The PEAD projected a Bearish outlook for $INCY after a Negative Under reaction following its earnings release placing the stock in drift D with an expected accuracy of 100%.
WATCH $INCY CUP AND HANDLEBullish
Fundamental
- High inflationary Macro environment / still no fear form retail sentiment
- Decent Accumulation/Distribution
- Decent PE
- Decent PEG
- Decent P/FCF
- Top Sector / Industry
- Fundamental sound company with a Cup and handle play / short term
Technical
- Momentum Theory Indi
INCY - Bearish ActionI expect INCY to show bearish traits following this post
As price moves along the bearish red trend line
This bearish action may stop along the dotted white line, this would be the better entry for INCY
$INCY with a Bullish outlook following its earnings #Stocks The PEAD projected a Bullish outlook for $INCY after a Positive Under reaction following its earnings release placing the stock in drift A with an expected accuracy of 75%.
19/5/2022 NASDAQ (INCY)Short (Entry Price) below the black line and exit (Stop Loss) above the red line. Can take profit at the suggested Target Price.
Entry Price: $74.62
Target Price: $73.86
Stop Loss: $75.89
See all ideas
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Curated watchlists where INCY is featured.
Frequently Asked Questions
The current price of INCY is 52.52 USD — it has decreased by 0.57% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Incyte Corporation stocks are traded under the ticker INCY.
Incyte Corporation is going to release the next earnings report on Apr 30, 2024. Keep track of upcoming events with our Earnings Calendar.
INCY stock is 1.16% volatile and has beta coefficient of 0.90. Check out the list of the most volatile stocks — is Incyte Corporation there?
One year price forecast for Incyte Corporation has a max estimate of 92.00 USD and a min estimate of 60.00 USD.
INCY earnings for the last quarter are 1.10 USD per share, whereas the estimation was 0.83 USD resulting in a 31.93% surprise. The estimated earnings for the next quarter are 1.15 USD per share. See more details about Incyte Corporation earnings.
Incyte Corporation revenue for the last quarter amounts to 919.03 M USD despite the estimated figure of 963.63 M USD. In the next quarter revenue is expected to reach 1.00 B USD.
Yes, you can track Incyte Corporation financials in yearly and quarterly reports right on TradingView.
INCY stock has fallen by 4.02% compared to the previous week, the month change is a 9.50% fall, over the last year Incyte Corporation has showed a 28.68% decrease.
INCY net income for the last quarter is 201.08 M USD, while the quarter before that showed 171.27 M USD of net income which accounts for 17.41% change. Track more Incyte Corporation financial stats to get the full picture.
Today Incyte Corporation has the market capitalization of 11.86 B, it has decreased by 1.40% over the last week.
No, INCY doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, INCY shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Incyte Corporation stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 19, 2024, the company has 2.52 K employees. See our rating of the largest employees — is Incyte Corporation on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Incyte Corporation technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Incyte Corporation stock shows the strong sell signal. See more of Incyte Corporation technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on Incyte Corporation future price: according to them, INCY price has a max estimate of 92.00 USD and a min estimate of 60.00 USD. Read a more detailed Incyte Corporation forecast: see what analysts think of Incyte Corporation and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Incyte Corporation EBITDA is 734.43 M USD, and current EBITDA margin is 19.87%. See more stats in Incyte Corporation financial statements.